Keep up to date with every new upload!

Join free & follow Extra Credit: S&P Global Ratin
Share
  • 2 years ago
The S&P Pharma Dose - Episode 11: Four Takeaways - Eli Lilly

The S&P Pharma Dose - Episode 11: Four Takeaways - Eli Lilly

Analyst Arthur Wong discusses the ratings and outlook on Eli Lilly, in the wake of the company’s upbeat earnings guidance despite the recent loss of its high profile drug prospect, the Alzheimer’s treatment, solanezumab.

Comments